Tradestie Institutional Equity Comparison Engine

AAME vs MURA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AAME Overall Edge

AAME Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Atlantic American Corp (AAME) driven by superior Valuation, Growth & Margin while MURA counters with relative strength in Momentum & Technical. Fundamentally, AAME trades at 7.4x Forward P/E with 5.1% operating margin (+4.8% YoY revenue) versus MURA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AAME sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MURA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AAME
AAME 7.4x vs MURA N/M Fwd P/E
Growth & Margin Winner AAME
Op Margin 5.1% vs 0.0% ยท YoY +4.8% vs +0.0%
Momentum & Technical Winner MURA
1Y -60.9% vs -51.4% ยท 52W Pos 8% vs 28%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AAME NASDAQ
Atlantic American Corp
Life Insurance
$1.18
-6.35% 1D
Market Cap $25.7M
1M Return +12.38%
1Y Return -60.93%
Forward P/E 7.4x
Unified AI Score
42.1 / 100 HOLD
Tech 45.0 Fund 49.0 Flow 50.0 Mom 60.0
MURA NASDAQ
Mural Oncology plc Ordinary Shares
Pharmaceutical Preparations
$2.03
+0.0% 1D
Market Cap $35.0M
1M Return -2.4%
1Y Return -51.44%
Forward P/E N/M
Unified AI Score
44.8 / 100 HOLD
Tech 25.0 Fund 36.0 Flow 50.0 Mom 35.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AAME -60.93% MURA -51.44% Spread: +15.34 pp (MURA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AAME TTM Op. Margin: 5.1% MURA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AAME vs MURA. Trailing 12-month operating profitability (AAME 5.1% vs MURA 0.0%) and valuation multiples (AAME 7.4x vs MURA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AAME (6) vs MURA (3)
Institutional Metric AAME MURA Criterion Row Winner
Market Capitalization Scale $25.7M $35.0M Larger Scale Tie
Trailing P/E Ratio Valuation 4.5x N/M Lower Multiple AAME
Forward P/E Ratio Valuation 7.4x N/M Lower Multiple AAME
Revenue Growth (YoY) Growth +4.8% +0.0% Higher Growth AAME
Operating Margin (TTM) Profitability 5.1% 0.0% Higher Margin AAME
Net Profit Margin Profitability 2.9% 0.0% Higher Margin AAME
Return on Equity (ROE) Capital Efficiency 5.2% -103.9% Higher ROE AAME
52-Week Range Position Momentum 8% ($1โ€“$3) 28% ($1โ€“$5) Stronger Trend MURA
Beta / 30D Volatility Risk Regime 0.92ฮฒ ยท 116% Vol 0.39ฮฒ ยท 16% Vol Lower Realized Risk MURA
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 44.8 / 100 (HOLD) Higher Composite MURA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AAME vs MURA Buy Guide
AAME UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AAME Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MURA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MURA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AAME nor MURA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.